Vyvgart 20 mg/mL concentrate for solution for infusion
HUB-MGEFG-001
Approved small_molecule active
Quick answer
Vyvgart 20 mg/mL concentrate for solution for infusion for Patients affected by generalized myasthenia gravis is a Approved program (small_molecule) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Patients affected by generalized myasthenia gravis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active